Furthermore, GR-dependent fat mass- and obesity-associated (FTO) transactivation and m6A demethylation on mRNA of lipogenic genes are involved in the pathogenesis of NAFLD [104]. The gene discussed is NR3C1; the disease is metabolic dysfunction-associated steatotic liver disease.